Cardiac resynchronization refers to pacing techniques that change the degre
e of atrial and ventricular electromechanical asynchrony in patients with m
ajor atrial and ventricular conduction disorders. Atrial and ventricular re
synchronization is usually accomplished by pacing from more than one site i
n an electrical chamber-atrium or ventricle-and occasionally by stimulation
at a single unconventional site. Resynchronization produces beneficial hem
odynamic and antiarrhythmic effects by providing a more physiologic pattern
of depolarization. Atrial resynchronization may prevent atrial fibrillatio
n in selected patients with underlying bradycardia or interatrial block. It
s antiarrhythmic effect in the absence of bradycardia is unclear. Ventricul
ar resynchronization is of far greater clinical value than atrial resynchro
nization. Biventricular (or single-chamber left ventricular) pacing is bene
ficial for patients with congestive heart failure, severe left ventricular
systolic dysfunction, dilated cardiomyopathy (either ischemic or idiopathic
), and a major left-sided intraventricular conduction disorder, such as lef
t bundle branch block. The chan-c in electrical activation from resynchroni
zation, which has no positive inotropic effect as such, is translated into
mechanical improvement with a more coordinated left ventricular contraction
. Several recent randomized trials and a number of observational studies ha
ve demonstrated the long-term effectiveness of ventricular resynchronizatio
n in the above group of patients. The high incidence of sudden death among
these patients has encouraged ongoing clinical trials to evaluate the benef
it of a system that combines biventricular pacing and cardioversion-defibri
llation into a single implantable device. (C) 2001 by Excerpta Medica, Inc.